svb enhanc product offer invest bank
oper ep may exclud certain item quarter may sum year due round
market data recent avail data
headquart santa clara california svb
group bank hold compani
serv emerg growth matur compani
technolog life scienc privat equiti
premium wine industri offer diversifi
financi servic silicon valley bank
svb analyt svb capit svb global
svb privat client servic compani
provid client commerci invest
intern privat bank servic
dealer transact asset manag
full rang servic privat equiti
compani svb oper offic throughout
 intern oper china
israel unit kingdom
deal diversifi fee incom expand opportun health
last week svb announc acquir boston ma-bas leerink partner
privat invest bank focus life scienc health care industri
leerink offer suit invest bank servic client includ
equiti convert capit market underwrit advisori servic
current svb serv life scienc health care client tradit
commerci bank product separ space four categori
healthcar it/digit health medic devic biopharma diagnost
health care servic total svb life scienc health care client repres
billion total client fund billion total loan
outstand manag note lend categori could outpac growth
vertic cite mega fund round caus debt
becom smaller share capit structur technolog space
leerink acquisit expand product suit svb offer exist client
broaden exposur wider set health care client jeff leerink
founder ceo key personnel remain respect
posit rebrand subsidiari svb leerink transact alreadi
approv leerink unithold pend regulatori approv finra hsr
anti-trust expect close mid-quart
deal term make longer earnback all-cash deal result
million payment leerink unithold million perform retent
sandler neill partner right reserv sandler neill seek busi
compani cover research report result investor awar sandler neill may
conflict interest could affect object report investor consid report
singl factor make invest decis pleas see import disclosur analyst
certif appendix report
pool paid five year key employe deal consider valu leerink ttm pre-tax
incom includ retent pool view full fair price transact manag
expect deal accret ep ep respect produc
irr exclud goodwil intang meanwhil deal expect dilut tangibl book valu
five-year earnback period use crossov method ad back equiti compens intang
amort use standard calcul earnback nearli doubl period longer investor
typic like see believ explain initi weak share immedi follow deal
announc deal reflect strateg entri new busi line svb lack cost save
found tradit bank acquisit longer earnback also reflect svb decis pay deal cash
rather use strong stock currenc like stem compani grow capit posit pro forma
tce ratio drop basi point
partnership offer potenti revenu synergi enhanc client servic revenu synergi
identifi includ svb forecast deal expect boost non-interest incom percentag
revenu ratio basi point upsid could even greater given expand suit servic
svb abl provid exist life scienc health care client mani svb client use
product firm grow larger servic offer help captur bigger share
relationship addit touch point manag assum cost save deal
leerink manag team key employe sign employ retent agreement point
svb resolut maintain leerink client-centr cultur deep sector expertis allow invest
bank oper fashion sinc found notabl svb second shot acquir
invest bank first alliant partner purchas million deal work
hope svb ultim wrote goodwil gener benefit lesson learn
manag confid deal posit outcom excit opportun creat
leerink partner profil opportun leerink found jeff leerink headquart
boston also offic new york san francisco charlott month end septemb
invest bank gener million revenu pre-tax effici ratio revenu
mostli gener equiti capit market underwrit invest bank also offer convert capit
underwrit advisori servic sale trade equiti research asset manag roughli
million aum notabl leerink rank fourth deal valu deal count health care equiti rais sinc
fourth deal valu deal count health care convert rais sinc eleventh third
respect deal valu deal count health care advisori servic sinc partner svb
heighten leerink exposur potenti revenu opportun svb life scienc healthcar
client septemb vc-back us life scienc healthcar compani went public ytd
svb client us life scienc health care compani complet secondari offer
ytd svb client equiti market main revenu center leerink svb manag also
focus build practic belief advisori convert underwrit
driver growth notabl equiti capit market revenu affect market volatil manag note
leerink strong slow year recent convert capit market advisori tend
less affect market movement
share repurchas author announc svb also announc board approv repurchas
million share expir mid-novemb current market price amount repres
outstand share base manag suggest plan fulli util author
come year allow flexibl respons chang market oper environ part
specul compani fairli activ buy-back current share price activ
wane stock climb meaning higher say back notabl pend acquisit time
complet affect repurchas activ even leerink acquisit full util
repurchas author would still leav compani well capit forma acquisit full buy-back
would trim hold compani ratio bp leverag ratio less bp
respect septemb ratio drift higher recent period capit
accumul pace exceed balanc sheet growth impact capit bank level
rais ep estim introduc estim incorpor leerink acquisit assum
half share repurchas author util rais ep estim
ep estim also introduc ep estim price
target ep estim repres premium multipl compar commerci bank
justifi svb uniqu franchis above-averag growth superior deposit base upsid
target reiter buy rate
net avail common
eop loan net unearn incom
compani report sandler neill
million except per share data
time dissemin novemb et
attest view express report accur reflect person view secur and/
industri cover report date report part compens
directli indirectli relat specif recommend view express report s/
attest view express report accur reflect person view secur and/or
industri cover report date report part compens
directli indirectli relat specif recommend view express report s/ thoma
